XNK Therapeutics

Pharmaceutical, Therapeutics

Founded in 1/1/11

Huddinge, Stockholms Lan, Sweden

http://www.xnktherapeutics.com/en/

For Profit

About XNK Therapeutics

XNK Therapeutics is a clinical stage, immunotherapy company focusing its efforts on preventing and treating cancer by developing novel NK cell-based therapies. The company has established a leadership position in the clinical development and manufacture of autologous NK cell-based products using its proprietary technology platform. The company's platform technology and leading investigational drug candidate have ideal properties for targeting cancers, including settings where allogeneic cell products are not readily applicable. It is foreseen that the product will bring a critical component to tomorrow's cancer treatment strategies. XNK Therapeutics is headquartered in Stockholm, Sweden

Company Metrics

Employees: 11-50
Monthly Visits: None
Tech Stack: None active products

Financial Information

Estimated Revenue:
Total Funding: 196000000 SEK
Last Funding: 132000000 SEK (Venture - Series Unknown)
Funding Status:

Technology Stack

XNK Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Pharmaceutical, Therapeutics

Headquarters: Huddinge, Stockholms Lan, Sweden

Employees